GenesisCare Appoints David Young as Chief Executive Officer

SYDNEY, Australia – April 11, 2023 – GenesisCare, one of the largest providers of integrated cancer care in Australia, the United States, the United Kingdom and Spain, today announced the appointment of David Young as Chief Executive Officer (“CEO”), effective 17 April 2023.

Mr Young is an experienced and respected industry leader, and brings to GenesisCare his significant experience having held senior executive positions in international healthcare services businesses. Mr Young was most recently President and CEO of PE GI Solutions, the largest single-specialty developer, owner and manager of gastrointestinal illness practices in the United States. He was previously the Chief Operating Officer of Privia Health Inc., a physician practice management and medical group also in the United States. Mr Young has also previously served as Chief Financial Officer of US Oncology and as Senior Vice President of Operations for McKesson Specialty Health following the combination with US Oncology.

In addition to the appointment of Mr Young as CEO, GenesisCare announced that healthcare industry veteran Dr Roy Beveridge will join the Company as a Senior Advisor.

Dr Beveridge is the former Senior Vice President and Chief Medical Officer of Humana, Inc., where he was responsible for developing and implementing Humana’s clinical strategy. He has also served as Chief Medical Officer for McKesson Specialty Health, including the US Oncology network.

These appointments represent a new chapter of senior leadership at GenesisCare and reinforce a steadfast commitment to enabling doctors and clinical staff to deliver world-class care to patients everywhere the Company operates.

Dr Michael Guiney, GenesisCare Chairman, said: “On behalf of the GenesisCare Board, I would like to extend a warm welcome to David and Roy. Their deep industry experience and track record of empowering doctors across large-scale provider networks complements GenesisCare’s mission and values.”

“We thank all our employees for their longstanding dedication to delivering excellent patient care and we look forward to embarking on a new and exciting partnership under David’s leadership to strengthen and accelerate GenesisCare’s growth and innovation,” Dr Guiney added.

Commenting on his appointment, David Young said: “It is an honour and a privilege to join GenesisCare, an organisation that delivers critically important care and services to cancer patients. GenesisCare’s doctors and clinical staff are our greatest strength, and my priority as CEO will be to enable them to do their best work every day. I look forward to working in partnership with the talented team to create new direction and momentum for GenesisCare in each of our core markets – Australia, the United States, the United Kingdom and Spain.”

****

About GenesisCare

Headquartered in Sydney, Australia, GenesisCare is a global healthcare company and one of the world’s largest integrated oncology organisations. The company’s purpose is to design care experiences that get the best possible life outcomes. This is grounded in the belief that care should be focused on the individual, not the condition.

GenesisCare is the world’s largest provider of radiotherapy – a vital treatment option for cancer patients – and provides patients with access to diagnostics, medical oncology, surgical oncology, and novel therapies alongside the ability to participate in the latest clinical trials. With a growing research and trials program numbering more than 150 clinical trials, a contract research organisation, and global innovation programs focused on precision medicine and novel therapies, GenesisCare is committed to improving clinical outcomes through new therapies.

Every year, GenesisCare’s clinical teams see more than 400,000 people at more than 440 locations across Australia, Europe and the US. The organisation employs more than 5,500 highly trained physicians, healthcare professionals and support staff. For more information, visit GC.com

Background on David Young

Most recently, from 2018 to 2023, Mr Young was President and CEO of PE GI Solutions (previously known as Physicians Endoscopy, Inc.) under the ownership of both Kelso & Co. and the subsequent sale to United Healthcare. PE GI Solutions is the largest single-specialty developer, owner and manager of gastrointestinal illness practices in the US. Prior to leading PE GI Solutions, Mr Young was Chief Operating Officer of Privia Health, Inc., a US physician practice management and medical group. Mr Young’s extensive industry experience also includes executive roles at Smile Brands, Inc., McKesson Specialty Health, and US Oncology. Mr Young holds a Bachelor of Science degree in Accounting and received his MBA from the University of Strathclyde in Glasgow. He is a Chartered Financial Analyst, Certified Public Accountant, Chartered Accountant, and Corporate Treasurer.

Background on Dr Roy Beveridge

Dr Beveridge is the former Senior Vice President and Chief Medical Officer of Humana, Inc., where he was responsible for developing and implementing Humana’s clinical strategy with an emphasis on advancing the company’s integrated care delivery model. He brings deep strategic leadership skills to GenesisCare and will support Mr Young in the execution of the group’s strategy. Dr Beveridge has also served as the Chief Medical Officer for McKesson Specialty Health. In addition to his exemplary executive career, Dr Beveridge is a board-certified Medical Oncologist who completed his medical degree at Cornell University Medical College, followed by a residency in internal medicine at the University of Chicago Hospital and fellowship at Johns Hopkins Hospital.

Media:

Scott McFarlane

Teneo

M: +61 493 119 547

E: Scott.McFarlane@teneo.com